United Ther
Article Abstract:
The price appreciation potential of United Therapeutics Corp. for the years 2010-2012 is discussed. The Silver Spring, Maryland-based company develops and markets treatments for cancers, cardiovascular diseases, and infectious diseases..
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Drugs, United Therapeutics Corp.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Abraxis BioScience
Article Abstract:
The shares of Abraxis BioScience have a below average price appreciation potential over the 2010-2012 timeframe. The Los Angeles, California-based company manufactures and distributes Abraxane, a nanoparticle chemotherapeutic compound.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
United States, Commercial physical research, Biological products exc. diagnostic, Analyst report
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Biotechnology industry, Biotechnology industries, Stocks, Securities, Stock prices, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.